Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
European Journal of Medicinal Chemistry|August 1, 2008
N-acylated and N,N'-diacylated imidazolidine-2-thione derivatives and N,N'-diacylated tetrahydropyrimidine-2(1H)-thione analogues: synthesis and antiproliferative activitySara Cesarini, Andrea Spallarossa, Angelo Ranise, et al.
Cancers|November 13, 2021
New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase InhibitorsAna Podolski-Renić, Jelena Dinić, Tijana Stanković, et al.
Archiv Der Pharmazie|December 25, 2015
Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance RegulatorErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-<i>d</i>]pyrimidines for Targeting Hepatocellular CarcinomaPierpaolo Calandro, Giulia Iovenitti, Claudio Zamperini, et al.
Journal of Chemical Information and Modeling|September 5, 2013
Identification of new Fyn kinase inhibitors using a FLAP-based approachGiulio Poli, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Cancers|June 18, 2020
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In VivoMarija Nešović, Aleksandra Divac Rankov, Ana Podolski-Renić, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 25, 2016
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for InhibitionCristina Talarico, Vincenzo Dattilo, Lucia D'Antona, et al.
Molecules (Basel, Switzerland)|September 20, 2018
Optimization of Aminoimidazole Derivatives as Src Family Kinase InhibitorsCinzia Maria Francini, Francesca Musumeci, Anna Lucia Fallacara, et al.
Pharmaceutics|July 27, 2024
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits InteractionIlaria Giacchello, Annarita Cianciusi, Chiara Bertagnin, et al.
Chemmedchem|March 28, 2009
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitorsFederico Falchi, Fabrizio Manetti, Fabio Carraro, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
European Journal of Medicinal Chemistry|August 1, 2008
N-acylated and N,N'-diacylated imidazolidine-2-thione derivatives and N,N'-diacylated tetrahydropyrimidine-2(1H)-thione analogues: synthesis and antiproliferative activitySara Cesarini, Andrea Spallarossa, Angelo Ranise, et al.
Cancers|November 13, 2021
New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase InhibitorsAna Podolski-Renić, Jelena Dinić, Tijana Stanković, et al.
Archiv Der Pharmazie|December 25, 2015
Phenylhydrazones as Correctors of a Mutant Cystic Fibrosis Transmembrane Conductance RegulatorErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-<i>d</i>]pyrimidines for Targeting Hepatocellular CarcinomaPierpaolo Calandro, Giulia Iovenitti, Claudio Zamperini, et al.
Journal of Chemical Information and Modeling|September 5, 2013
Identification of new Fyn kinase inhibitors using a FLAP-based approachGiulio Poli, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Cancers|June 18, 2020
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In VivoMarija Nešović, Aleksandra Divac Rankov, Ana Podolski-Renić, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 25, 2016
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for InhibitionCristina Talarico, Vincenzo Dattilo, Lucia D'Antona, et al.
Molecules (Basel, Switzerland)|September 20, 2018
Optimization of Aminoimidazole Derivatives as Src Family Kinase InhibitorsCinzia Maria Francini, Francesca Musumeci, Anna Lucia Fallacara, et al.
Pharmaceutics|July 27, 2024
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits InteractionIlaria Giacchello, Annarita Cianciusi, Chiara Bertagnin, et al.
Chemmedchem|March 28, 2009
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitorsFederico Falchi, Fabrizio Manetti, Fabio Carraro, et al.
Pageof 18